Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Weight Loss

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Weight Loss in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Weight Loss: Decrease in existing BODY WEIGHT.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parmentier, S1
Böhme, GA1
Lerouet, D1
Damour, D1
Stutzmann, JM1
Margaill, I1
Plotkine, M1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Weight Loss

ArticleYear
Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury.
    British journal of pharmacology, 1999, Volume: 127, Issue:2

    Topics: Amidines; Animals; Benzylamines; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; E

1999